FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5609511000001106: Liquivisc 0.25% eye gel (Allergan Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18857101000001117 Liquivisc 0.25% eye gel (Allergan Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
94139301000001112 Liquivisc 0.25% eye gel (Thea Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Liquivisc 0.25% eye gel (Allergan Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Is a Carbomer 974P 0.25% eye gel true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has active ingredient Carbomer 974P false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has active ingredient Carbomer-974P false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Is a Liquivisc true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has specific active ingredient Carbomer-974P true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has active ingredient Carbomer true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has manufactured dose form Ocular dose form true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) Has dispensed dose form Conventional release eye gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Liquivisc 0.25% eye gel (Allergan Ltd) 10 gram Is pack of False Liquivisc 0.25% eye gel (Allergan Ltd) Inferred relationship Existential restriction modifier
Liquivisc 0.25% eye gel (Allergan Ltd) 10 gram Has AMP True Liquivisc 0.25% eye gel (Allergan Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start